Safety Study of AB0024 in Patients With Advanced Solid Tumors

  • participants needed
  • sponsor
    Arresto Biosciences, Inc.
Updated on 8 November 2020


This is a first-in-human, open-label, sequential dose escalation study to evaluate AB0024 in patients with advanced solid tumors.


Patients will receive four infusions of AB0024 every two weeks starting on Day 1 until Day 43. Patients will be seen weekly for safety assessments and collection of blood samples until Day 71. Patients who do not show evidence of disease progression by clinical assessment or by CT or MRI prior to Day 71 may continue receiving AB0024 every 2 weeks starting on Day 71 until disease progression (clinical or radiographic), study drug intolerance, or withdrawal of consent.

Condition Solid Tumors, Cancer
Treatment AB0024
Clinical Study IdentifierNCT01158872
SponsorArresto Biosciences, Inc.
Last Modified on8 November 2020


How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note